Advertisement
Screener

BEONE MEDICINES LTD. (ONC) Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

2.8 / 5 stars · 68/120 Roast Me

BEONE MEDICINES LTD. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

BEONE MEDICINES LTD. (ONC) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $39.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Change in Cash

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05

  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $19.32M, a 455.17% increase year-over-year.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $3.48M.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$22.44M, a 298.37% decline year-over-year.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $11.31M, a 25.68% increase year-over-year.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $60.02M.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$51.70M.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$8.08M.
  • BEONE MEDICINES LTD. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$69.38M, a 594.36% decline from fiscal 2021.
Period endEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month
2026-06-30$39.16M
10-Q · filed 2026-08-05
2026-03-31$19.32M
10-Q · filed 2026-05-06
2025-12-31$60.02M
10-K · filed 2026-02-26
2025-09-30$36.86M
10-Q · filed 2025-11-06
2025-06-30$26.96M
10-Q · filed 2026-08-05
2025-03-31$3.48M
10-Q · filed 2026-05-06
2024-12-31-$51.70M
10-K · filed 2026-02-26
2024-09-30$8.00K
10-Q · filed 2025-11-06
2024-06-30-$28.34M
10-Q · filed 2025-08-06
2024-03-31-$22.44M
10-Q · filed 2025-05-07
2023-12-31-$8.08M
10-K · filed 2026-02-26
2023-09-30-$50.35M
10-Q · filed 2024-11-12
2023-06-30-$50.87M
10-Q · filed 2024-08-07
2023-03-31$11.31M
10-Q · filed 2024-05-08
2022-12-31-$69.38M
10-K · filed 2025-02-27
2022-09-30-$133.93M
10-Q · filed 2023-11-09
2022-06-30-$71.21M
10-Q · filed 2023-08-02
2022-03-31$9.00M
10-Q · filed 2023-05-04
2021-12-31$14.04M
10-K · filed 2024-02-26
2021-09-30$6.77M
10-Q · filed 2022-11-09
2021-06-30$5.26M
10-Q · filed 2022-08-08
2021-03-31-$4.06M
10-Q · filed 2022-05-09
2020-12-31$18.23M
10-K · filed 2023-02-27
2020-09-30$4.34M
10-Q · filed 2021-11-04
2020-06-30-$4.29M
10-Q · filed 2021-08-05
2020-03-31-$6.21M
10-Q · filed 2021-05-06
2019-12-31-$9.51M
10-K · filed 2022-02-28
2019-09-30-$18.34M
10-Q · filed 2020-11-05
2019-06-30-$2.73M
10-Q · filed 2020-08-06
2019-03-31$4.26M
10-Q · filed 2020-05-11
2018-12-31-$4.10M
10-K · filed 2021-02-25
2018-09-30-$5.86M
10-Q · filed 2019-11-12
2018-06-30$1.78M
10-Q · filed 2019-08-08
2018-03-31$3.44M
10-Q · filed 2019-05-09
2017-09-30$2.76M
10-Q · filed 2018-11-08
2017-06-30$240.00K
10-Q · filed 2018-08-09
2017-03-31-$129.00K
10-Q · filed 2018-05-09